A Common Variant Is Associated with Low Agreeableness and Neural Responses to Working Memory Tasks in ADHD
Overview
Authors
Affiliations
The cell-cell signaling gene is associated with a wide spectrum of neuropsychiatric disorders, including attention-deficit/hyperactivity disorder (ADHD), autism, and major depression. regulates axonal outgrowth and synapse formation, substantiating its relevance for neurodevelopmental processes. Several studies support the influence of on personality traits, behavior, and executive functions. However, evidence for functional effects of common gene variation in the gene in humans is sparse. Therefore, we tested for association of a functional intronic SNP rs2199430 with ADHD in a sample of 998 adult patients and 884 healthy controls. The Big Five personality traits were assessed by the NEO-PI-R questionnaire. Assuming that altered neural correlates of working memory and cognitive response inhibition show genotype-dependent alterations, task performance and electroencephalographic event-related potentials were measured by n-back and continuous performance (Go/NoGo) tasks. The rs2199430 genotype was not associated with adult ADHD on the categorical diagnosis level. However, rs2199430 was significantly associated with agreeableness, with minor G allele homozygotes scoring lower than A allele carriers. Whereas task performance was not affected by genotype, a significant heterosis effect limited to the ADHD group was identified for the n-back task. Heterozygotes (AG) exhibited significantly higher N200 amplitudes during both the 1-back and 2-back condition in the central electrode position Cz. Consequently, the common genetic variation of is associated with personality traits and impacts neural processing during working memory tasks. Thus, might contribute to symptomatic core dysfunctions of social and cognitive impairment in ADHD.
Yokomori T, Tozaki T, Ohnuma A, Ishimaru M, Sato F, Hori Y Behav Genet. 2024; 54(4):333-341.
PMID: 38856811 DOI: 10.1007/s10519-024-10186-x.
Learning and Memory Impairments With Attention-Deficit/Hyperactivity Disorder.
Tien T, Xu X, Song J, Zhang X, Zhang D, Yuan H Physiol Res. 2024; 73(2):205-216.
PMID: 38710050 PMC: 11081185.
Novel pharmacological targets for GABAergic dysfunction in ADHD.
Ferranti A, Luessen D, Niswender C Neuropharmacology. 2024; 249:109897.
PMID: 38462041 PMC: 11843668. DOI: 10.1016/j.neuropharm.2024.109897.
Association of the gene variant rs9940180 with schizophrenia risk in North Indian population.
Gupta S, Priya I, Arora M, Singh H, Sharma I, Sharma S Am J Transl Res. 2023; 15(11):6476-6485.
PMID: 38074818 PMC: 10703641.
Special Issue: Genetics of Psychiatric Disease and the Basics of Neurobiology.
Rodriguez-Revenga L, Alvarez-Mora M Genes (Basel). 2022; 13(11).
PMID: 36360245 PMC: 9690469. DOI: 10.3390/genes13112008.